Recent Finacing
Recent Raise
Riogin develops modified peptide therapeutics and technical solutions to extend peptide half-lives, reduce dosing frequency, and mitigate side effects through in-house assays and peptide engineering.
Focus Areas
Recent Investors
Funding round
Investor